temozolomide has been researched along with chlorotoxin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Payne, CA; Safdar, S; Taite, LJ; Tu, NH | 1 |
| Ghosh, S; Ifediba, MA; Medarova, Z; Moore, A; Yoo, B | 1 |
2 other study(ies) available for temozolomide and chlorotoxin
| Article | Year |
|---|---|
Targeted nitric oxide delivery preferentially induces glioma cell chemosensitivity via altered p53 and O(6) -methylguanine-DNA methyltransferase activity.
Topics: Antineoplastic Agents; Brain Neoplasms; Carmustine; Dacarbazine; Drug Resistance, Neoplasm; Glioblastoma; Humans; Nitric Oxide; O(6)-Methylguanine-DNA Methyltransferase; Scorpion Venoms; Temozolomide; Tumor Suppressor Protein p53 | 2013 |
Combination treatment with theranostic nanoparticles for glioblastoma sensitization to TMZ.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Dacarbazine; Glioblastoma; Humans; Iron; Mice; Nanoparticles; O(6)-Methylguanine-DNA Methyltransferase; RNA, Small Interfering; Scorpion Venoms; Temozolomide; Xenograft Model Antitumor Assays | 2014 |